AMG-PERK-44 |
AMG-PERK-44 : Inhibitor of EIF2AK3
Probe Summary
Selectivity
Potency
In Vivo
Control Compounds
Chemical Information
References
Vendors
Download
Probe Summary
| Targets | Biochemical/Biophysical Potency | Cellular Potency |
|---|---|---|
| EIF2AK3 |
|
|
Inhibitor
10 mg/kg for in vivo use
1 µM
Selectivity
In Vitro Selectivity Assessment
EIF2AK4
Gene ID: Q9P2K8
Organism: Homo sapiens
Family: Ser/Thr protein kinase family
Potency: IC50 - 7300 nM
Potency Assay Off-Target:
TR-FRET assay (using 120 µM ATP (= 0.66 x Km), Cisbio Inc.)
Selectivity Assessment Description:
Screened at 1 µM against 387 kinases, KINOMEscan (DiscoveRx). Clean selectivity profile, no target w ...
Potency Cellular
In Vitro
EIF2AK3
Mode of Action: Inhibitor
Structure-Activity-Relationship data available? Yes
DOI Reference: 10.1021/jm5017494
In Vivo Validations
Mouse
Dose: 2.5 mg/kg
Route of delivery:
Oral
Plasma half life:
MRT = 5.0 h
Area Under the Curve::
1.4 µM x h
Fb :
55%
Volume of Distribution at Steady-State:
3.6 L/kg
Target engagement assay:
Compounds dosed in male CD-1 mice as a solution at 2.5 mg/kg po in 1% Pluronic F68/1% HPMC/15% Captisol/83% H2O, pH 2.0, with MsOH.
DOI Reference: 10.1021/jm5017494
Chemical Information
| Molecular Formula | C34H28N4O2 |
| SMILEs | Cc1ccc2cc(-c3c(C)ccc(C(=O)c4c(-c5ccccc5)n(C)n(-c5ccccc5)c4=O)c3N)ccc2n1 |
| InChI | InChI=1S/C34H28N4O2/c1-21-14-18-27(31(35)29(21)25-17-19-28-24(20-25)16-15-22(2)36-28)33(39)30-32(23-10-6-4-7-11-23)37(3)38(34(30)40)26-12-8-5-9-13-26/h4-20H,35H2,1-3H3 |
| Molecular weight | 524.22 Da |
| AlogP | 6.48824 |
| HBond acceptors | 6 |
| HBond donors | 2 |
| Atoms | 68 |
| PAINS * | Yes |
* This is an automated alert only, and may not necessarily indicate an issue with this probe. ( Learn more about PAINS )